aAlthough 1 spoke to him amny times ,he never took any motice of what 1 said 虽然1与他谈了话amny时期,他未曾采取什么的所有motice 1认为[translate] aAlpha Lipid IQ 1 - Infant Formul 阿尔法油脂智商1 -婴儿Formul[translate] aExecution of the work 工作的施行[translate] ...
MOTI $0.00 VanEck Morningstar International Moat ETF0.00% FTVNX $0.00 FullerThaler Behavioral Mid-Cap Value Fund Inv0.00% ORAGX $0.00 OR MFS 529 Savings Plan Lifetime Income Fund A0.00% ZTIP.F:CA $0.00 BMO Short-Term US TIPS Index ETF (Hedged Units)0.00% SP400-60103010:IND $0.00 S&P ...
Technicals Sorry, this data cannot be displayed at the moment. Discover More You may be interested in: BJK $43.10 VanEck Gaming ETF+1.10% BCHIX $9.72 American Century California High Yield Municipal Fund Inst+0.02% CXGCX $12.82 Calamos Global Convertible Fund Inst+0.08% MOTI $33.03 VanEck...
Markets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings. Continue with Google Continue with Apple or Create Free Account By creating an account using any of the options above, you agree to theTerms of Use&Privacy Policy ...
Sorry, this data cannot be displayed at the moment. Discover More You may be interested in: NLST $0.00 Netlist, Inc.0.00% LCEAX $0.00 Invesco Diversified Dividend Fund A0.00% OEPSX $0.00 Oil Equipment & Services UltraSector ProFund S0.00% MOTI $0.00 VanEck Morningstar International Moat ETF...
Latest on MOAT:MOAT, MOTI: Unilever Passes Another Moat Test Macro Trading Factory 4.9 The Macro Teller Themes: Macro Asset Allocation Latest on MOAT:Please, Sir, May I Have Some More Please? Ratings Summary SourceNow6M ago SA Analysts ...
Similar to EKTAF Sorry, this data cannot be displayed at the moment. ETFs Holding EKTAF SymbolLast PriceChange MOTI 33.50 0.39% VanEck Morningstar International Moat ETF ROBO 59.69 -0.53% Robo Global® Robotics and Automation Index ETF KNO 45.74 -0.37% AXS Knowledge Leaders ETF ISVL 36...
The company’s pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple ...
First Trust Germany AlphaDEX® Fund ETF FEUZ 40.80 0.05% First Trust Eurozone AlphaDEX® ETF MOTI 30.27 0.30% VanEck Morningstar International Moat ETF DRIV 23.93 0.08% Global X Autonomous & Electric Vehicles ETF IDRV 30.51 0.90% iShares Self-Driving EV and Tech ETFSeeking...
The company’s pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple ...